Nls Pharmaceutics Ag Stock Alpha and Beta Analysis
| NLSPW Stock | USD 0.01 0 18.18% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as NLS Pharmaceutics AG. It also helps investors analyze the systematic and unsystematic risks associated with investing in NLS Pharmaceutics over a specified time horizon. Remember, high NLS Pharmaceutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to NLS Pharmaceutics' market risk premium analysis include:
Beta (5.14) | Alpha 4.58 | Risk 36.04 | Sharpe Ratio 0.12 | Expected Return 4.47 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
NLS |
NLS Pharmaceutics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. NLS Pharmaceutics market risk premium is the additional return an investor will receive from holding NLS Pharmaceutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in NLS Pharmaceutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate NLS Pharmaceutics' performance over market.| α | 4.58 | β | -5.14 |
NLS Pharmaceutics expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of NLS Pharmaceutics' Buy-and-hold return. Our buy-and-hold chart shows how NLS Pharmaceutics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.NLS Pharmaceutics Market Price Analysis
Market price analysis indicators help investors to evaluate how NLS Pharmaceutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading NLS Pharmaceutics shares will generate the highest return on investment. By understating and applying NLS Pharmaceutics stock market price indicators, traders can identify NLS Pharmaceutics position entry and exit signals to maximize returns.
NLS Pharmaceutics Return and Market Media
The median price of NLS Pharmaceutics for the period between Thu, Aug 29, 2024 and Wed, Nov 27, 2024 is 0.014 with a coefficient of variation of 28.71. The daily time series for the period is distributed with a sample standard deviation of 0.0, arithmetic mean of 0.01, and mean deviation of 0.0. The Stock received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | NLS Pharmaceutics Ltd. Announces Closing of Private Placement and Expected Compliance with Nasdaq Continued Listing Rules - Yahoo Finance | 10/15/2024 |
2 | NLS Pharmaceutics Ltd. Regains Full Compliance with Nasdaq Listing Requirements | 10/28/2024 |
3 | NLS Pharmaceutics Highlights Innovative Preclinical Program for First-in-Class Non-Sulfonamide Dual Orexin Receptor Agonists in Narcolepsy and Neurological Diso... | 11/18/2024 |
About NLS Pharmaceutics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including NLS or other stocks. Alpha measures the amount that position in NLS Pharmaceutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards NLS Pharmaceutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, NLS Pharmaceutics' short interest history, or implied volatility extrapolated from NLS Pharmaceutics options trading.
Build Portfolio with NLS Pharmaceutics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for NLS Stock Analysis
When running NLS Pharmaceutics' price analysis, check to measure NLS Pharmaceutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NLS Pharmaceutics is operating at the current time. Most of NLS Pharmaceutics' value examination focuses on studying past and present price action to predict the probability of NLS Pharmaceutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NLS Pharmaceutics' price. Additionally, you may evaluate how the addition of NLS Pharmaceutics to your portfolios can decrease your overall portfolio volatility.